Search database
Filter
3055
Text search: drug quality
Featured
Language
Document type
2593
200
116
68
32
20
17
5
2
2
Countries
238
106
98
95
93
90
80
80
77
75
68
65
64
62
55
52
47
45
38
37
37
32
29
27
22
19
19
18
16
16
15
15
14
13
13
10
8
7
7
6
6
6
6
6
6
4
4
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
247
245
123
89
87
61
53
37
33
32
30
26
25
23
23
22
21
20
20
20
18
17
16
15
14
14
14
14
14
14
13
13
13
12
12
11
11
11
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1536
261
129
123
65
54
39
1
1
Toolboxes
359
300
151
111
71
58
52
50
40
37
33
28
26
21
16
13
10
9
8
6
2
 Add to my MEDBOX

Report National Tuberculosis Drug Resistance Survey, 2006-2007

National Center for TB and Leprosy Control (CENAT) , Cambodia (2011) CC
 Download
  View PDF
 Add to my MEDBOX

Prevention of Drug Use and Treatment of Drug Use Disorders in Rural Settings
recommended

United Nations Office on Drug and Crime UNODC (2017) C1
 Download
  View PDF
 Add to my MEDBOX

National HIV Service Quality Improvement Tool Kit

Ministry of Health, Ethiopia (2018) C1
 Add to my MEDBOX

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
recommended

Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al. World Health Organization (WHO) (2016) C_WHO
 External Link
 Add to my MEDBOX

Improving Private Drug Sellers’ Practices for Managing Common Health Problems in Nepal

Kafle KK., Karkee SB., Shrestha N., et al. JNHRC (2013) C1
J Nepal Health Res Counc 2013 May;11(24):198-204
 Download
  View PDF
 Add to my MEDBOX

Access to and Quality of Menstrual Regulation and Postabortion Care in Bangladesh: Evdence from a Survey of Health Facilities, 2014

Altaf Hossain, Isaac Maddow-Zimet, Meghan Ingerick et al. Guttmacher Institute (2017) C1
 Add to my MEDBOX

List of Medicines for Rural Drug Vendor, Ethiopia (LMRDV)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2011) C1
Fourth edition
 Download
  View PDF
 Add to my MEDBOX

National Strategy on HIV Drug Resistance Monitoring and Surveillance in Nepal 2014-2020
recommended

Government of Nepal Ministry of Health and Population Department of Health Services, National Centre for AIDS and STD Control (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users in Kathmandu Valley, Round I, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1
 Download
  View PDF
 Add to my MEDBOX

India: Guidelines for Quality Assurance of smear microscopy for diagnosing tuberculosis

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare (2005) C1
 Download
  View PDF
 Add to my MEDBOX

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda: THE NATIONAL DRUG POLICY AND AUTHORITY (REGISTRATION) REGULATIONS, 2014

The Government of Uganda The Uganda Gazette (2014) C2
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
 Download
  View PDF
 Add to my MEDBOX

Management of drug-resistant tuberculosis

World Health Organization (2014) C_WHO
Training for staff working at DR-TB management centres. Training modules
 Download
  View PDF
 Add to my MEDBOX

Situational analysis of quality improvement in maternal and neonatal health care, Sierra Leone

United Nations Population Fund UNFPA (2018) CC
 Download
  View PDF
 Add to my MEDBOX

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1
Accessed November 2017
 Download
  View PDF
 Add to my MEDBOX

Policy Implementation Package for new TB drug introduction (Russian version)

World Health Organization Europe Всемирная организация здравоохранения (2014) C_WHO
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
 Download
  View PDF
 Add to my MEDBOX

Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB

World Health Organization Europe (2016) C_WHO
Results of the first national survey, 2013–2014
 Download
  View PDF
 Add to my MEDBOX

Public health dimension of the world drug problem

World Health Organization WHO (2022) C_WHO
Report by the Director-General. 75th World health assembly 25 April 2022
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

International Standards for the Treatment of Drug Use Disorders
recommended

World Health Organization, United Nations Office on Drugs and Crime (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the programmatic management of drug-resistant tuberculosis

World Health Organization (2011) C_WHO
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention an ... more
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date

H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

TIP 18: The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers: Treatment Improvement Protocol (TIP) Series 18

D. H. Mulligan, U.S Department of health and human service (1995) C2
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

Rencana aksi nasional: Programmatic Management of Drug Resistance Tuberculosis, Pengendalian Tuberkulosis Indonesia 2011-2014

Kementerian Kesehatan Republik Indonesia (2011) C1
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Download
  View PDF
 Add to my MEDBOX

Good Pharmacy Practice - Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services

World Health Organization (WHO), International Pharmaceutical Federation (FIP) (2011) C_WHO
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na ... more
 Download
  View PDF
 Add to my MEDBOX

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO
The END TB strategy
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies

World Health Organization (2017) C_WHO
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
 Download
  View PDF
 Add to my MEDBOX

GUIDELINE ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF A MULTISOURCE (GENERIC) FINISHED PHARMACEUTICAL PRODUCT (FPP): QUALITY PART IN THE COMMON TECHNICAL DOCUMENT (CTD) FORMAT

Medicines Control Authority of Zimbabwe (MCAZ) (2012) C2
 External Link
 Add to my MEDBOX

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al. International Journal of Molecular Scienes (2017) C2
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more
 Download
  View PDF
 Add to my MEDBOX

Harsh punishment - The Human Toll of Georgia’s Abusive Drug Policies

G. Gogia Human Rights Watch (2018) C2
 Download
  View PDF
 Add to my MEDBOX

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode ... more
 Add to my MEDBOX

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
 Download
  View PDF
 Add to my MEDBOX

Updated Guidelines for Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India

NACO (2013)
 Download
  View PDF
 Add to my MEDBOX

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis
recommended

World Health Organization WHO (2018) C_WHO
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
 Add to my MEDBOX

Health Information System Strategic Plan 2008-2015 , accountability, efficiency, quality, equity

Ministry of Health, Cambodia (2008) CC
 Download
  View PDF
 Add to my MEDBOX

Technical Report: Size Estimation of Sex Workers, Men who have Sex with Men, and Drug Users in Liberia

Simon-Pierre TEGANG, Jemee K. TEGLI (2011) C1
 Download
  View PDF
 Add to my MEDBOX

Medicines Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
 Download
  View PDF
 Add to my MEDBOX

Diagnostics Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
 Download
  View PDF
 Add to my MEDBOX

How to take medicines safely

German Agency for Quality in Medicine (ÄZQ) (2011) C1
Patient information on safe medical treatment. Available in: Arabic, English, French, Russian, Spanish, Turkish, German. This is the English version. For other language versions visit: http://www.patienten-information.de/kurzinformationen/arzneimittel-und-impfungen/sichere-arzneimitteltherapie
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Registration Guidelines for Medical Devices Bangladesh 2015

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Instructions for Completing Suspected Adverse Event Reporting Form

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2014) C1
 Add to my MEDBOX

Survey of Adherence to Antiretroviral Medicine inEthiopia

Ethiopian Drug Administration and Control Authority (DACA); et al. USAID (2007) C1
 Add to my MEDBOX

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug ... more
 Add to my MEDBOX

Formulary of Narcotic Drugs and Psychotropic Substances for Ethiopia

Drug Administration and Control Authority (DACA) of Ethiopia (2004) C1
 Download
  View PDF
 Add to my MEDBOX

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - ANNEXES

National Drug Authority (NDA), Uganda (2017) C1
Doc. No.: INS/GDL/001-(Annexes)
 Download
  View PDF
 Add to my MEDBOX

Strategies to prevent diversion of opioid substitution treatment medications

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products Bangladesh

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Bangladesh Multiple Indicator Cluster Survey 2012-2013, Progotir Pathey. Key Findings

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh; UNICEF (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Women speak out: understanding women who inject drugs in Indonesia

Indonesian Drug Users Network (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Executive Summary - Conclusions and policy implications

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -1- Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide

National Institute on Drug Abuse (2014) C2
 Download
  View PDF
 Add to my MEDBOX

Ghana: GUIDELINES FOR SAFETY MONITORING OF MEDICINAL PRODUCTS

Food and Drug Authority (FDA), Ghana (2016) C2
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 | These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
 Download
  View PDF
 Add to my MEDBOX

Changes in Europe’s cannabis resin market

European Monitoring Centre for Drugs and Drug Addiction (2017) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

New heroin-assisted treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. Strang; T. Groshkova; N. Metrebian European Monitoring Centre for Drugs and Drug Addiction; Publications Office (2019) C2
EMCDDA Insights - 11 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Uzbekistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
 Download
  View PDF
 Add to my MEDBOX

Country overview: Tajikistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Moldova country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 28.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Georgia

J.D. Javakhishvili; L. Sturua; I. Kirtadze; et al. European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Montenegro country overview

J. Sekulić European Monitoring Centre for Drugs and Drug Addiction (2011) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

Comorbidity of substance use and mental health disorders in Europe

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on drugs
 Download
  View PDF
 Add to my MEDBOX

North Macedonia

L. Savikj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of synthetic drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Amphetamine-type stimulants, new psychoactive substances -4- World Drug Report 2017 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of plant-based drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Opiates, cocaine, cannabis World Drug Report 2017 -3- Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Successful Community Nutrition Programming: Lessons from Kenya , Tanzania, and Uganda

LINKAGES, L., Regional Centre for Quality of Health Care, R. and United Nations Children's Fund , U. (2002) CC
 Download
  View PDF
 Add to my MEDBOX

HIV in prisons Situation and needs assessment toolkit

United Nations Office4 on Drugs and Crime; European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Advance copy.
 External Link
 Add to my MEDBOX

Practice Parameter on Disaster Preparedness

Pfefferbaum, B., Shaw, J.A. & American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) American Academy of Child and Adolescent Psychiatry (AACAP) (2013) CC
AACAP OFFICIAL ACTION | This Practice Parameter identifies best approaches to the assessment and management of children and adolescents across all phases of a disaster. Delivered within a disaster system of care, many interventions are appropriate for implementation in the weeks and months after a d ... more
 Add to my MEDBOX

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

World Health Organization WHO (2007) C_WHO
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of ... more
 Add to my MEDBOX

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu KIT (Royal Tropical Institute) Development Policy & Practice Vrije Universiteit Amsterdam (2008) CC
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
 Download
  View PDF
 Add to my MEDBOX

MSF Qualification Scheme for International Pharmaceutical Supply

Medicins Sans Frontieres (2009) CC
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedu ... more
 Download
  View PDF
 Add to my MEDBOX

Botswana: Guidelines on Good Manufacturing Practices

Ministry of Health, Gabarone, Botswana (2009) C2
Drug Advisory Board
 Download
  View PDF
 Add to my MEDBOX

Clinical Facility and Services Assessment Field Guide
recommended

USAID; Family Health International FHI (2007) C1
Quality Assurance (QA) and Quality Improvement (QI). The guide provides general information on how to organize, implement and follow up on quality ... more
 Download
  View PDF
 Add to my MEDBOX

Integrated TB-HIV Outpatient Clinical Service (OPC) QA/QI Checklist

Family Health International FHI (2007) C1
This field guide is designed for use by FHI 360 staff and partner organizations responsible for ensuring quality clinical services, at both facility and non-facility levels. The guide provides general information on how to organize, implement and fo ... more
 External Link
 Add to my MEDBOX

Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia)
recommended

Ministry of Health & Social Welfare, Liberia (2011) C1
Essential Drug list on page 36!!
 Add to my MEDBOX

Laboratory Diagnosis of Malaria. Operational Guidelines for Laboratory Technicians

Government of India; National Vector Borne Diseases Control Programme; Ministry of Health & Family Welfare NVBDCP (2009) CC
SOP- Quality Assurance of Malaria Diagnostic Tests
 Add to my MEDBOX

A practical handbook on the pharmacovigilance of antiretroviral medicines

World Health Organization WHO (2013) C_WHO
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica ... more
 Download
  View PDF
 Add to my MEDBOX

Namibia: National Health Policy Framework 2010-2020

Ministry of Health and Social Services (MOHSS) (2010) C1
“towards quality health and social welfare services”
 Download
  View PDF
 Add to my MEDBOX

The National Health Strategy for Zimbabwe (2009-2013)

Ministry of Health Zimbabwe (2009) C1
Equity and Quality in Health: a People's Right
 Download
  View PDF
 Add to my MEDBOX

Maternal and Newborn Health Toolkit

Maternal Health Division Department of Family Welfare Government of India (2013) C1
To provide quality maternal and newborn health services at health facilities in India.
 Download
  View PDF
 Add to my MEDBOX

Drugs and age - Drugs and associated issues among young people and older people

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -4-
 Download
  View PDF
 Add to my MEDBOX

Identifying characteristics associated with performing recommended practices in maternal and newborn care among health facilities in Rwanda: a cross-sectional study

Sipsma, H.L., Curry, L.A., Kakoma, J.P., Linnander, E.L., & Bradley, E.H. Human Resources for Health (2012) CC
This study examined the quality of facility-based maternal and newborn health care by describing the implementation of recommended practices for maternal and newborn care among health care facilities to determine whether increased training, supervis ... more
 Download
  View PDF
 Add to my MEDBOX

Task sharing policy guidelines 2017-2030

Ministry of Health, Kenya (2017) C1
Expanding access to quality health services through task sharing
 Add to my MEDBOX

WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children

World Health Organization (2010) C_WHO
To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management of infections such as pneumonia, diarrhoea, malaria ... more
 Add to my MEDBOX

Malawi Health Sector Strategic Plan 2011 - 2016
recommended

Ministry of Health, Malawi (2012) C1
Moving towards equity and quality
 Download
  View PDF
 Add to my MEDBOX

Treat as One. Bridging the gap between mental and physical healthcare in general hospitals

National Confidential Enquiry into Patient Outcome and Death (2017) C1
This NCEPOD report highlights the quality of mental health and physical health care for patients aged 18 years or older with a significant mental disorder who are admitted to a general hospital. The report takes a critical look at areas where the ca ... more
 Download
  View PDF
 Add to my MEDBOX

Treatment of tuberculosis - Annex 3 Grade evidence profiles

World Health Organization (2017) C_WHO
Guidelines for treatment of drug-susceptible tuberculosis and patient care 2017 update